Epitope editing is presented as an engineering strategy in AML CAR T-cell therapy.
First-pass extracted concept
epitope editing
Candidate: concept label2 source documents3 linked claims
Live refresh every 5sNext refresh in 5s
Extracted Explainers
Evidence Snippets
Multiantigen targeting, logic-gated designs, and epitope editing have emerged to improve specificity and safety
In this review, we summarize the main approaches that have been developed to face such bottlenecks, including... epitope editing...
Supporting Sources
Linked Claims
Multiantigen targeting, logic-gated designs, and epitope editing have emerged to improve specificity and safety in AML CAR T-cell therapy.
Quoted textsource-backed
Multiantigen targeting, logic-gated designs, and epitope editing have emerged to improve specificity and safety
The review summarizes adapter CAR systems, Boolean-logic gating, epitope editing, modulation of cell-intrinsic signaling pathways, safety switches, and co-stimulatory domain selection as main approaches to address CAR-T bottlenecks.
CAR-engineered T-cell therapy has achieved unprecedented response rates in some hematological malignancies but remains far from fulfilling its potential, especially in solid cancers.